1995
DOI: 10.1159/000139313
|View full text |Cite
|
Sign up to set email alerts
|

Biliary Cef piramide Excretion: Its Relation to Biliary Excretion of Bile Acids and Sulfobromophthalein

Abstract: Cefpiramide, a β-lactam antibiotic, has been reported to be excreted from hepatocytes into the bile by a carrier-mediated system. Herein, the relationship of biliary cefpiramide excretion to the excretion of bile acids and sulfobromophthalein was studied in rats. Biliary cefpiramide excretion was markedly inhibited by sulfobromophthalein, lithocholate-3-O-glucuronide and taurolithocholate-3-sulfate, whereas it was not inhibited by ursodeoxycholate or taurocholate. However, the inhibitory effect of cefpiramide … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
2
0

Year Published

1997
1997
2005
2005

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 13 publications
2
2
0
Order By: Relevance
“…CPM and PS significantly increased bile flow to 140 and 190% of that in the control rats, respectively, as previously reported [28,29] (data not shown). Among the organic anions, only BSP significantly decreased biliary EM excretion (table 1).…”
Section: Biliary Em Excretion In Ehbr Was Somewhat Slower Than In Consupporting
confidence: 89%
“…CPM and PS significantly increased bile flow to 140 and 190% of that in the control rats, respectively, as previously reported [28,29] (data not shown). Among the organic anions, only BSP significantly decreased biliary EM excretion (table 1).…”
Section: Biliary Em Excretion In Ehbr Was Somewhat Slower Than In Consupporting
confidence: 89%
“…2, Table 1). Bile flow was increased by the infusion of cefpiramide and pravastatin as reported previously (data not shown) 17,18 . In contrast, TC and TUDC did not inhibit biliary excretion of olmesartan in SDR (Fig.…”
Section: Resultssupporting
confidence: 86%
“…These results strongly suggest that olmesartan is a substrate of Mrp2. This is further confirmed by the inhibition of the biliary excretion of olmesartan by Mrp2 substrates, BSP, 21 cefpiramide 17 and pravastatin 18,22 . Because only a part of olmesartan in the bile was glucuronidated both in SDR and EHBR, it was hard to compare the affinity of olmesartan and its glucuronide for Mrp2.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation